{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T12:51:17Z","timestamp":1790859077830,"version":"4.1.0"},"reference-count":47,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100006483","name":"AbbVie","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006483","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001003","name":"Boehringer Ingelheim","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001003","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Dermatologic Clinics"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1016\/j.det.2024.12.003","type":"journal-article","created":{"date-parts":[[2024,12,30]],"date-time":"2024-12-30T12:27:52Z","timestamp":1735561672000},"page":"173-178","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Comorbidities and Quality of Life in Hidradenitis Suppurativa"],"prefix":"10.1016","volume":"43","author":[{"given":"Bria","family":"Midgette","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amit","family":"Garg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.det.2024.12.003_bib1","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1016\/j.clindermatol.2023.08.021","article-title":"Hidradenitis suppurativa and follicular occlusion syndrome: where is the pathogenetic link?","volume":"41","author":"Jastrz\u0105b","year":"2023","journal-title":"Clin Dermatol"},{"issue":"5","key":"10.1016\/j.det.2024.12.003_bib2","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1016\/j.jaad.2018.09.040","article-title":"Overall and subgroup prevalence of acne vulgaris among patients with hidradenitis suppurativa","volume":"80","author":"Wertenteil","year":"2019","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"10","key":"10.1016\/j.det.2024.12.003_bib3","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.1111\/jdv.15071","article-title":"Prevalence and comorbidities associated with hidradenitis suppurativa in Korea: a nationwide population-based study","volume":"32","author":"Lee","year":"2018","journal-title":"J\u00a0Eur Acad Dermatol Venereol"},{"issue":"4","key":"10.1016\/j.det.2024.12.003_bib4","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1007\/s13555-018-0264-z","article-title":"The comorbidity burden of hidradenitis suppurativa in the United States: a claims data analysis","volume":"8","author":"Kimball","year":"2018","journal-title":"Dermatol Ther (Heidelb)"},{"issue":"3","key":"10.1016\/j.det.2024.12.003_bib5","doi-asserted-by":"crossref","first-page":"191","DOI":"10.2165\/11595240-000000000-00000","article-title":"Etiology and management of pyoderma gangrenosum: a comprehensive review","volume":"13","author":"Ahronowitz","year":"2012","journal-title":"Am J Clin Dermatol"},{"issue":"1","key":"10.1016\/j.det.2024.12.003_bib6","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1111\/bjd.20086","article-title":"Neutrophil trafficking: the missing link in the pathogenesis of hidradenitis suppurativa","volume":"185","author":"Giamarellos-Bourboulis","year":"2021","journal-title":"Br J Dermatol"},{"issue":"3","key":"10.1016\/j.det.2024.12.003_bib7","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1111\/bjd.14214","article-title":"Keratinocytes and neutrophils are important sources of proinflammatory molecules in hidradenitis suppurativa","volume":"174","author":"Lima","year":"2016","journal-title":"Br J Dermatol"},{"issue":"4","key":"10.1016\/j.det.2024.12.003_bib8","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1007\/s40257-017-0265-1","article-title":"PAPA, PASH and PAPASH syndromes: pathophysiology, presentation and treatment","volume":"18","author":"Cugno","year":"2017","journal-title":"Am J Clin Dermatol"},{"issue":"6","key":"10.1016\/j.det.2024.12.003_bib9","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1016\/j.jaad.2019.02.004","article-title":"Overall and subgroup prevalence of pyoderma gangrenosum among patients with hidradenitis suppurativa: a population-based analysis in the United States","volume":"80","author":"Tannenbaum","year":"2019","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"4","key":"10.1016\/j.det.2024.12.003_bib10","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/j.jaad.2013.11.014","article-title":"The prevalence of metabolic syndrome in patients with hidradenitis suppurativa","volume":"70","author":"Gold","year":"2014","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"6","key":"10.1016\/j.det.2024.12.003_bib11","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1007\/s40257-023-00796-2","article-title":"Disease burden and treatment patterns among US patients with hidradenitis suppurativa: a retrospective cohort study","volume":"24","author":"Garg","year":"2023","journal-title":"Am J Clin Dermatol"},{"issue":"12","key":"10.1016\/j.det.2024.12.003_bib12","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1001\/jamadermatol.2014.1165","article-title":"Association of metabolic syndrome and hidradenitis suppurativa","volume":"150","author":"Miller","year":"2014","journal-title":"JAMA Dermatol"},{"issue":"2","key":"10.1016\/j.det.2024.12.003_bib13","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1111\/bjd.13777","article-title":"Hidradenitis suppurativa and metabolic syndrome: a comparative cross-sectional study of 3207 patients","volume":"173","author":"Shalom","year":"2015","journal-title":"Br J Dermatol"},{"issue":"4","key":"10.1016\/j.det.2024.12.003_bib14","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1001\/jamadermatol.2015.6264","article-title":"Risk of major adverse cardiovascular events and all-cause mortality in patients with hidradenitis suppurativa","volume":"152","author":"Egeberg","year":"2016","journal-title":"JAMA Dermatol"},{"issue":"1","key":"10.1016\/j.det.2024.12.003_bib15","doi-asserted-by":"crossref","first-page":"82","DOI":"10.5114\/ada.2017.65626","article-title":"Increased serum interleukin-6 levels in patients with hidradenitis suppurativa","volume":"34","author":"Xu","year":"2017","journal-title":"Postepy Dermatol Alergol"},{"issue":"6","key":"10.1016\/j.det.2024.12.003_bib16","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1111\/ijd.17186","article-title":"Risk of cardiovascular disorders in hidradenitis suppurativa patients: a large-scale, propensity-matched global retrospective cohort study","volume":"63","author":"Krajewski","year":"2024","journal-title":"Int J Dermatol"},{"issue":"9","key":"10.1016\/j.det.2024.12.003_bib17","doi-asserted-by":"crossref","first-page":"8428","DOI":"10.3390\/ijms24098428","article-title":"New insight into the molecular pathomechanism and immunomodulatory treatments of hidradenitis suppurativa","volume":"24","author":"Molinelli","year":"2023","journal-title":"Int J Mol Sci"},{"issue":"1","key":"10.1016\/j.det.2024.12.003_bib18","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1001\/jamadermatol.2019.3412","article-title":"Incidence of myocardial infarction and cerebrovascular accident in patients with hidradenitis suppurativa","volume":"156","author":"Reddy","year":"2020","journal-title":"JAMA Dermatol"},{"issue":"6515","key":"10.1016\/j.det.2024.12.003_bib19","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1136\/bmj.292.6515.245","article-title":"Mediation of hidradenitis suppurativa by androgens","volume":"292","author":"Mortimer","year":"1986","journal-title":"Br Med J (Clin Res Ed)"},{"issue":"5Part B","key":"10.1016\/j.det.2024.12.003_bib20","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1016\/j.ijwd.2021.10.012","article-title":"Clinical considerations in the management of hidradenitis suppurativa in women","volume":"7","author":"Kozera","year":"2021","journal-title":"Int J Womens Dermatol"},{"issue":"6","key":"10.1016\/j.det.2024.12.003_bib21","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1016\/j.jid.2018.01.009","article-title":"Hidradenitis suppurativa is associated with polycystic ovary syndrome: a population-based analysis in the United States","volume":"138","author":"Garg","year":"2018","journal-title":"J\u00a0Invest Dermatol"},{"issue":"2","key":"10.1016\/j.det.2024.12.003_bib22","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.jaad.2023.04.044","article-title":"Prevalence of polycystic ovarian syndrome among children and adolescents with hidradenitis suppurativa","volume":"89","author":"Mastacouris","year":"2023","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"4","key":"10.1016\/j.det.2024.12.003_bib23","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1016\/j.jaad.2010.07.010","article-title":"Expression of the IL-23\/Th17 pathway in lesions of hidradenitis suppurativa","volume":"65","author":"Schlapbach","year":"2011","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"Supplement_2","key":"10.1016\/j.det.2024.12.003_bib24","doi-asserted-by":"crossref","first-page":"ii3","DOI":"10.1093\/ecco-jcc\/jjac034","article-title":"Interleukin-23 in the pathogenesis of inflammatory bowel disease and implications for therapeutic intervention","volume":"16","author":"Sewell","year":"2022","journal-title":"J\u00a0Crohns Colitis"},{"issue":"22","key":"10.1016\/j.det.2024.12.003_bib25","doi-asserted-by":"crossref","first-page":"8847","DOI":"10.3390\/ijms21228847","article-title":"Notch signaling regulation in autoinflammatory diseases","volume":"21","author":"Gratton","year":"2020","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.det.2024.12.003_bib26","doi-asserted-by":"crossref","first-page":"865131","DOI":"10.3389\/fmed.2022.865131","article-title":"Overview of three proliferation pathways (wnt, notch, and hippo) in intestine and immune system and their role in inflammatory bowel diseases (IBDs)","volume":"9","author":"Khoramjoo","year":"2022","journal-title":"Front Med (Lausanne)"},{"issue":"7","key":"10.1016\/j.det.2024.12.003_bib27","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1001\/jamadermatol.2018.0878","article-title":"Overall and subgroup prevalence of Crohn disease among patients with hidradenitis suppurativa: a population-based analysis in the United States","volume":"154","author":"Garg","year":"2018","journal-title":"JAMA Dermatol"},{"issue":"5","key":"10.1016\/j.det.2024.12.003_bib28","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1016\/j.jid.2016.11.040","article-title":"Prevalence and risk of inflammatory bowel disease in patients with hidradenitis suppurativa","volume":"137","author":"Egeberg","year":"2017","journal-title":"J\u00a0Invest Dermatol"},{"issue":"8","key":"10.1016\/j.det.2024.12.003_bib29","doi-asserted-by":"crossref","first-page":"1716","DOI":"10.1016\/j.jid.2016.04.003","article-title":"Hidradenitis suppurativa and inflammatory bowel disease: a cross-sectional study of 3,207 patients","volume":"136","author":"Shalom","year":"2016","journal-title":"J\u00a0Invest Dermatol"},{"issue":"9","key":"10.1016\/j.det.2024.12.003_bib30","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1001\/jamadermatol.2019.0891","article-title":"Association of hidradenitis suppurativa with inflammatory bowel disease: a systematic review and meta-analysis","volume":"155","author":"Chen","year":"2019","journal-title":"JAMA Dermatol"},{"issue":"1","key":"10.1016\/j.det.2024.12.003_bib31","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1111\/pde.14012","article-title":"Follicular occlusion disorders in Down syndrome patients","volume":"37","author":"Firsowicz","year":"2020","journal-title":"Pediatr Dermatol"},{"issue":"3","key":"10.1016\/j.det.2024.12.003_bib32","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1111\/bjd.15770","article-title":"Prevalence of hidradenitis suppurativa among patients with Down syndrome: a population-based cross-sectional analysis","volume":"178","author":"Garg","year":"2018","journal-title":"Br J Dermatol"},{"issue":"2","key":"10.1016\/j.det.2024.12.003_bib33","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1111\/j.1365-2249.2009.03890.x","article-title":"Intrinsic defect of the immune system in children with Down syndrome: a review","volume":"156","author":"Kusters","year":"2009","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.det.2024.12.003_bib34","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.ridd.2016.06.018","article-title":"Overweight and obesity in children and adolescents with Down syndrome-prevalence, determinants, consequences, and interventions: a literature review","volume":"57","author":"Bertapelli","year":"2016","journal-title":"Res Dev Disabil"},{"issue":"6","key":"10.1016\/j.det.2024.12.003_bib35","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1111\/bjd.12887","article-title":"The possible association of hidradenitis suppurativa and Down syndrome: is increased amyloid precursor protein expression resulting in impaired Notch signalling the missing link?","volume":"170","author":"Blok","year":"2014","journal-title":"Br J Dermatol"},{"issue":"1","key":"10.1016\/j.det.2024.12.003_bib36","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1111\/jdv.16677","article-title":"Hidradenitis suppurativa: an update on epidemiology, phenotypes, diagnosis, pathogenesis, comorbidities and quality of life","volume":"35","author":"Nguyen","year":"2021","journal-title":"J\u00a0Eur Acad Dermatol Venereol"},{"issue":"4","key":"10.1016\/j.det.2024.12.003_bib37","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1111\/bjd.16101","article-title":"Population-based Clinical Practice Research Datalink study using algorithm modelling to identify the true burden of hidradenitis suppurativa","volume":"178","author":"Ingram","year":"2018","journal-title":"Br J Dermatol"},{"issue":"2","key":"10.1016\/j.det.2024.12.003_bib38","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1111\/jdv.12567","article-title":"Psychiatric comorbidities in 3207 patients with hidradenitis suppurativa","volume":"29","author":"Shavit","year":"2015","journal-title":"J\u00a0Eur Acad Dermatol Venereol"},{"issue":"1","key":"10.1016\/j.det.2024.12.003_bib39","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.jid.2017.09.008","article-title":"Increased suicide risk in patients with hidradenitis suppurativa","volume":"138","author":"Thorlacius","year":"2018","journal-title":"J\u00a0Invest Dermatol"},{"issue":"12","key":"10.1016\/j.det.2024.12.003_bib40","doi-asserted-by":"crossref","first-page":"2672","DOI":"10.1016\/j.jid.2018.06.171","article-title":"Women with hidradenitis suppurativa have an elevated risk of suicide","volume":"138","author":"Tiri","year":"2018","journal-title":"J\u00a0Invest Dermatol"},{"issue":"2","key":"10.1016\/j.det.2024.12.003_bib41","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.jaad.2019.06.1301","article-title":"Evaluating patients' unmet needs in hidradenitis suppurativa: results from the global survey of impact and Healthcare needs (VOICE) project","volume":"82","author":"Garg","year":"2020","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"6","key":"10.1016\/j.det.2024.12.003_bib42","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1093\/bjd\/ljad069","article-title":"Factors associated with disease-specific life impact in patients with hidradenitis suppurativa: results from the Global VOICE project","volume":"188","author":"Garg","year":"2023","journal-title":"Br J Dermatol"},{"issue":"2","key":"10.1016\/j.det.2024.12.003_bib43","first-page":"502","article-title":"Incidence of sexual dysfunction among patients with hidradenitis suppurativa: a population-based retrospective analysis","volume":"179","author":"Slyper","year":"2018","journal-title":"Br J Dermatol"},{"issue":"1","key":"10.1016\/j.det.2024.12.003_bib44","doi-asserted-by":"crossref","first-page":"389","DOI":"10.3390\/ijerph20010389","article-title":"Sexual dysfunction and quality of life in patients with hidradenitis suppurativa and their partners","volume":"20","author":"Cuenca-Barrales","year":"2022","journal-title":"Int J Environ Res Public Health"},{"issue":"4","key":"10.1016\/j.det.2024.12.003_bib45","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1111\/bjd.14922","article-title":"A\u00a0pilot study of unemployment in patients with hidradenitis suppurativa in Denmark","volume":"176","author":"Theut Riis","year":"2017","journal-title":"Br J Dermatol"},{"issue":"4","key":"10.1016\/j.det.2024.12.003_bib46","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1016\/j.jaad.2009.09.021","article-title":"Hidradenitis suppurativa markedly decreases quality of life and professional activity","volume":"62","author":"Matusiak","year":"2010","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"6","key":"10.1016\/j.det.2024.12.003_bib47","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1111\/bjd.21798","article-title":"Factors associated with treatment satisfaction in patients with hidradenitis suppurativa: results from the Global VOICE project","volume":"187","author":"Midgette","year":"2022","journal-title":"Br J Dermatol"}],"container-title":["Dermatologic Clinics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0733863524001037?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0733863524001037?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T17:30:36Z","timestamp":1751391036000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0733863524001037"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4]]},"references-count":47,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,4]]}},"alternative-id":["S0733863524001037"],"URL":"https:\/\/doi.org\/10.1016\/j.det.2024.12.003","relation":{},"ISSN":["0733-8635"],"issn-type":[{"value":"0733-8635","type":"print"}],"subject":[],"published":{"date-parts":[[2025,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comorbidities and Quality of Life in Hidradenitis Suppurativa","name":"articletitle","label":"Article Title"},{"value":"Dermatologic Clinics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.det.2024.12.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}